Contact us Career

Press Release

In Vitro Diagnostic Quality Control Market Worth $1,220 million by 2026

July, 2020

" COVID-19 Impact on In Vitro Diagnostic Quality Control market, size, share, growth, and forecast 2020-2026 "

The In Vitro Diagnostic Quality Control is the controlling of the accuracy and stability of the in vitro diagnostic test results. In vitro diagnostic is a type of test conducted by taking the samples of the blood or tissue from the body to diagnose the present condition of the patient. The In vitro diagnostic quality control market is growing rapidly and the factors that are driving this market are increasing volume of accredited clinical laboratories which need the quality control in the test results. However, the unfavorable reimbursements scenario in the in vitro diagnostic quality control market is restricting demand for products and services.

The rising demand for the proficiency testing that allows a laboratory to compare its testing procedures with other laboratory procedures is fueling demand for the in vitro diagnostic quality control market.

Request for sample report @ https://www.infoholicresearch.com/request-a-sample-report/?repid=14561

The In Vitro Diagnostic Quality Control Market report titled “In Vitro Diagnostic Quality Control Market by: Product, by Manufacturer, by Application, by End-User, by Geography– Forecast up to 2026” gives the total analysis of the market opportunities, drivers and challenges.

The top notch five companies in In Vitro Diagnostic Quality Control Market are Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Technopath Clinical Diagnostics, Randox Laboratories Ltd, and Bio-Techne Corporation.

Globally the major contributor in this market is North America region which has acquired a largest share in this market due to the increasing in vitro diagnostic test, and large number of hospitals in this region. The increasing use of third-party quality controls among the laboratories also fuel the demand for products and services. Europe is also expected to increase in the growth of this market due to improved life science industry and increasing research. In addition, the key promoters are present in these regions.

Access full report summary @ https://www.infoholicresearch.com/report/in-vitro-diagnostic-quality-control-market/

The report consists of 70+ Tables and 40+ charts depicting the in-depth market study and the impact analysis of COVID-19 by Vendor name. The report scope can be summarized as:

  • Product based market segmentation covered in study include:
    • Quality Control Products
    • Serum/Plasma-Based Controls
    • Whole Blood-Based Controls
    • Urine-Based Controls
    • Other Source-Based IVD Quality Controls
    • Data Management Solutions
    • Quality Assurance Services
  • Application based market segmentation covered in the report include:
    • Immunochemistry/Immunoassay
    • Clinical Chemistry
    • Hematology
    • Molecular Diagnostics
    • Coagulation & Hemostasis
    • Microbiology
    • Other Applications
  • Manufacturer segments studied and classified in the study are:
    • Third-Party Control Manufacturers
    • Independent Controls
    • Instrument-Specific Controls
    • Original Equipment Manufacturers
  • End-user categories covered in study are:
    • Hospitals
    • Clinical Laboratories
    • Academic & Research Institutes
    • Other End Users
  • Geographic segments of the study are:
    • North America
    • Europe
    • Asia Pacific
    • Rest of the World
  • Competitive landscape covering key players in the market

Mr. Karthick Subramani

Infoholic Research LLP

Marketing & Communication

karthick@infoholicresearch.com